未经证实的基于干细胞的干预措施的营销：行动呼吁。
Marketing of unproven stem cell-based interventions: A call to action.
机构信息
Riken Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Kobe 650-0047, Japan.
Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
出版信息
Sci Transl Med. 2017 Jul 5;9(397). doi: 10.1126/scitranslmed.aag0426.
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.
商业推广未经证实的干细胞治疗用途是一个全球性问题，已被证明难以通过监管措施加以解决。在此，我们建议在国家和国际层面采取协调一致的方法，重点是参与、协调和执法，以降低与未经证实的干细胞治疗直接面向消费者营销相关的风险。
Zotero 插件